
-
Aerovate Therapeutics NasdaqGM:AVTE Aerovate Therapeutics, Inc., a biopharmaceutical company, engages in the treatment of pulmonary arterial hypertension in the United States. Aerovate Therapeutics, Inc., was incorporated in 2018 and is headquartered in Waltham, Massachusetts.
Location: 930 Winter Street, Waltham, MA, 02451, United States | Website: https://www.aerovatetx.com | Industry: Biotechnology | Sector: Healthcare
Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
1.782M
Cash
76.21M
Avg Qtr Burn
-12.48M
Short % of Float
38.39%
Insider Ownership
0.02%
Institutional Own.
-
Qtr Updated
03/31/25
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
AV-101 Details Pulmonary arterial hypertension | Phase 2/3 Update |